The Executive Committee of the IHII is chaired by the Director of the IHII and serves to (1) advise the Director and membership of the IHII on Institute policies, (2) provide guidance concerning the research and scholarly activities of the Institute, and (3) approve appointments of members and associate members of the Institute, subject to the conditions of membership. The Executive Committee serves as a forum for discussion of matters relevant to the infectious disease and immunology research communities at UTMB, and accomplishes this purpose by meeting at least quarterly, or at other times at the call of the chair as circumstances dictate.

The Executive Committee of the IHII is comprised of
• Center Directors
  • Center for Biodefense and Emerging Infectious Diseases
    -- David H. Walker
  • Center for Hepatitis Research -- Stanley M. Lemon
  • Sealy Center for Vaccine Development -- Lawrence Stanberry
  • WHO-CC for Arboviruses and Hemorrhagic Fever Viruses -- Robert Tesh
  • WHO-CC for Tropical Diseases -- David H. Walker
• GNL Director -- Stanley M. Lemon
  
• GNL Associate Director for Research -- Alan D.T. Barrett
  
• Chair, Department of Microbiology & Immunology -- David Niesel
  
• Chair, Department of Pathology -- David H. Walker
  
• Director, Division of Infectious Diseases (Internal Medicine) -- Glen Mayhall
  
• Chair, McLaughlin Committee -- Lynn Soong
  
• School of Nursing representative -- Nonie Mendias
  
• Faculty representatives (2005-2007) -- C.J. Peters, Scott Weaver
  (2006-2008) (to be elected, 2006)

Faculty members of the IHII Executive Committee will be elected by the members of the IHII and will serve for overlapping terms of 2 years.